BL-B01D1
mAbexperimentalADCBi-specific
Clinical trial activity
38 trials · 10 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
33
Phase 3
10
Phase 4
0
Earliest trial started Nov 29, 2021 (NCT05194982)
Timeline
Indications
Studied for
- Biliary Tract Neoplasms · Phase 2
- Breast Neoplasms · Phase 3
- Carcinoma, Hepatocellular · Phase 2
- Carcinoma, Non-Small-Cell Lung · Phase 3
- Carcinoma, Ovarian Epithelial · Phase 3
- Carcinoma, Transitional Cell · Phase 3
- Chordoma · Phase 2
- Colorectal Neoplasms · Phase 2
- Endometrial Neoplasms · Phase 2
- Esophageal Neoplasms · Phase 2
- Esophageal Squamous Cell Carcinoma · Phase 3
- Fallopian Tube Neoplasms · Phase 3
- Glioblastoma · Phase 2
- Hamartoma · Phase 3
- Intestinal Neoplasms · Phase 1
- Kidney Neoplasms · Phase 2
- Lung Neoplasms · Phase 1
- Nasopharyngeal Carcinoma · Phase 3
- Nasopharyngeal Neoplasms · Phase 1
- Neoplasms · Phase 2
- Small Cell Lung Carcinoma · Phase 3
- Squamous Cell Carcinoma of Head and Neck · Phase 2
- Stomach Neoplasms · Phase 2
- Triple Negative Breast Neoplasms · Phase 3
- Urogenital Neoplasms · Phase 1/Phase 2
- Urologic Neoplasms · Phase 2
- Uterine Cervical Neoplasms · Phase 2
Mechanism of action
- Receptor protein-tyrosine kinase erbB-2ANTAGONIST
ERBB2 antagonist
- Receptor tyrosine-protein kinase erbB-3ANTAGONIST
ERBB3 antagonist
Chemistry & pharmacology
- Multi-specific
- Yes (Bi-specific)
- Payload
- Unclear
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07054567 | Phase 2 | Aug 21, 2025 | Baili Pharmaceutical Group |
| NCT06994195 | Phase 3 | Aug 4, 2025 | Baili Pharmaceutical Group |
| NCT06962787 | Phase 2 | Jul 28, 2025 | Baili Pharmaceutical Group |
| NCT06951464 | Phase 2 | Jun 25, 2025 | Sichuan University |
| NCT06986785 | Phase 2 | Jun 24, 2025 | Baili Pharmaceutical Group |
| NCT06978114 | Phase 2 | Jun 10, 2025 | Baili Pharmaceutical Group |
| NCT06857175 | Phase 3 | Mar 31, 2025 | Baili Pharmaceutical Group |
| NCT06838273 | Phase 3 | Feb 24, 2025 | Baili Pharmaceutical Group |
| NCT06787664 | Phase 2 | Jan 16, 2025 | Baili Pharmaceutical Group |
| NCT06598787 | Phase 2 | Oct 17, 2024 | Baili Pharmaceutical Group, Capital Medical University |
| NCT06500026 | Phase 3 | Aug 7, 2024 | Baili Pharmaceutical Group, Sun Yat-Sen University |
| NCT06471205 | Phase 2 | Aug 2, 2024 | Baili Pharmaceutical Group, Fudan University |
| NCT06498986 | Phase 2 | Jul 31, 2024 | Baili Pharmaceutical Group, Huazhong University of Science and Technology |
| NCT06475300 | Phase 2 | Jun 25, 2024 | Baili Pharmaceutical Group, Sun Yat-Sen University |
| NCT06382142 | Phase 3 | Jun 21, 2024 | Baili Pharmaceutical Group, Fudan University |
| NCT06437509 | Phase 2 | Jun 13, 2024 | Baili Pharmaceutical Group, Huazhong University of Science and Technology |
| NCT06437522 | Phase 2 | Jun 7, 2024 | Baili Pharmaceutical Group, Fudan University |
| NCT06405425 | Phase 2 | May 29, 2024 | Baili Pharmaceutical Group, Fudan University |
| NCT06382116 | Phase 3 | May 22, 2024 | Baili Pharmaceutical Group, Sun Yat-Sen University |
| NCT06382129 | Phase 3 | May 17, 2024 | Baili Pharmaceutical Group, Chinese Academy of Medical Sciences |
Showing 20 of 38 trials
Page 1 / 2
Organizations
Research & Development (10)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Baili Pharmaceutical Group | For profit | 36 | 36 | 3 | 2021 |
| Fudan University | Academic/Hospital | 9 | 0 | 2 | 2023 |
| Sun Yat-Sen University | Academic/Hospital | 6 | 0 | 3 | 2021 |
| SystImmune Inc. | For profit | 5 | 1 | 1 | 2021 |
| Peking University | Academic/Hospital | 4 | 0 | 3 | 2022 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 3 | 0 | 2 | 2023 |
| Huazhong University of Science and Technology | Academic/Hospital | 3 | 0 | 1 | 2023 |
| Capital Medical University | Academic/Hospital | 2 | 0 | 2 | 2022 |
| Jilin Provincial Tumor Hospital | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Sichuan University | Academic/Hospital | 1 | 1 | 1 | 2025 |
10 organizations
Page 1 / 1